Nifty 50 Top Gainers and Losers Today, September 29: Dr Reddy’s, Adani Stocks Gain; Titan Falls

The Indian benchmark indices extended their decline on Tuesday, September 29, with the Nifty 50 slipping below the 22,750 mark and the Sensex falling around 240 points. The selling came a day after the indices recorded their steepest decline of the financial year, taking the benchmarks closer to six-month lows.

The broader market also remained weak, with midcap and smallcap indices falling around 0.8%. Rising crude oil prices remained the biggest macro concern, with Brent crude climbing to around $107 a barrel. US Treasury yields also remained elevated, adding pressure to emerging-market equities and increasing concerns around India's import bill, inflation and growth.

The September F&O expiry added another layer of volatility to the session. Market participants were already watching 22,700 as an important technical level after the Nifty's sharp fall on Monday.

Top Nifty 50 Gainers

Dr Reddy's Laboratories led the Nifty gainers, extending the relative strength seen in parts of the pharma sector. Pharma stocks remained among the pockets of resilience even as the broader market stayed under pressure. The sector was also in focus after the US Commerce Department published details related to proposed tariffs on certain patented pharmaceutical imports and ingredients from September 29.

Kotak Mahindra Bank gained 1.05%, bucking the broader weakness across financial stocks.

Adani Enterprises and Adani Ports both gained around 1% after four Adani Group companies, including the two, settled proceedings with SEBI related to alleged minimum public shareholding violations. The settlement involved a payment of ₹1.48 crore and was made without admission or denial of the regulator's findings.

Tata Steel and Bharti Airtel also ended higher, providing some support to the benchmark despite the broader sell-off.

Top Nifty 50 Losers

Titan Company led the Nifty losers, falling 2.58% as the broader market sell-off intensified. The stock had already declined 1.31% on Monday as equities came under pressure.

IT stocks remained weak, with Wipro and HCL Technologies falling 2.56% and 1.92%, respectively. The sector continues to face concerns around muted growth, AI-led pricing pressure and uneven demand. Citi Research expects another year of subdued growth for Indian IT services companies, with TCS, Infosys and HCLTech among those facing limited growth expectations for FY27.

Max Healthcare and Apollo Hospitals also declined, adding to pressure on the healthcare pack.

Bajaj Auto fell 1.67% as the broader risk-off move extended to auto stocks. Elevated crude prices remain a concern for the sector as they can increase fuel and operating costs and add to pressure on consumption.

Midcap and Smallcap Movers

Among midcaps, Mankind Pharma gained 4.49%, followed by Indus Towers at 2.71% and One97 Communications at 2.59%.

On the losing side, PB Fintech declined 6.11%, while Coromandel International and Patanjali Foods fell 5.59% and 4.96%, respectively.

In the smallcap segment, Mangalore Refinery and Petrochemicals rose 3.16%, while Great Eastern Shipping and Brainbees Solutions gained 2.42% and 2.15%.

Welspun Corp was the biggest smallcap loser, falling 9.84%. Data Patterns and Netweb Technologies declined 9.74% and 8.22%, respectively.

What Investors Should Watch

Crude oil remains the key market trigger. Brent crude climbed around 1.5% to $107 a barrel on Tuesday as uncertainty around the US-Iran conflict continued, raising concerns over India's import bill, inflation and corporate profitability.

The Nifty's break below 22,700 is also being closely watched after the index breached its 200-week moving average on Tuesday, marking the first such break in six years according to the market report. The September expiry could add to volatility, while elevated US Treasury yields and foreign fund outflows remain additional pressure points for Indian equities.

Also Read - Nifty Faces Worst Year Since 2011 As Foreign Selling Intensifies